Quantcast

Global Central Nervous System Therapeutic Market by Disease, Region and Country (2019 Edition) – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global
Central Nervous System Therapeutic Market: Analysis By Disease, By
Region, By Country (2019 Edition): Opportunities and Forecast
(2014-2024)”
report has been added to ResearchAndMarkets.com’s
offering.

The Central Nervous System Therapeutic Market has been analyzed for the
historical period of 2014-2018 and the forecast period of 2019-2024.

According to the report, the global market is projected to display a
robust growth represented by a CAGR of 6.8% during 2019-2024.

The mental health has been witnessing growth at a noteworthy rate over
the past few years backed by rise in stress and depression among people
as well as increasing awareness and acceptance amongst people about
mental health.

Amongst the regions, Asia Pacific accounts for the largest regional
share in the global central nervous system therapeutic market in 2018.
Key factors driving the robust growth rate of Asia Pacific region
include rising geriatric population along with increasing incidences of
neurodegenerative diseases, increase in chronic ailments and growing per
capita healthcare expenditure worldwide.

The report has covered and analyzed the potential of Global Central
Nervous System Therapeutic market and provides statistics and
information on market size, shares and growth factors. The report
intends to provide cutting-edge market intelligence and help decision
makers take sound investment evaluation.

Besides, the report also identifies and analyses the emerging trends
along with major drivers, challenges and opportunities in the global
central nervous system therapeutic market. Additionally, the report also
highlights market entry strategies for various companies across the
globe.

Scope of the Report

Global Central Nervous System Therapeutic Market (Actual Period:
2014-2018, Forecast Period: 2019-2024

  • Global Central Nervous System Therapeutic Market – Size, Growth,
    Forecast
  • By Disease (Cancer, Neurovascular, Degenerative disorder, Mental
    Health, Trauma, Infection)

Regional Markets – North America, Europe, APAC and Rest of the
World (Actual Period: 2014-2018, Forecast Period: 2019-2024)

  • Central Nervous System Therapeutic Market – Size and Growth
  • By Disease (Cancer, Neurovascular, Degenerative disorder, Mental
    Health, Trauma, Infection)

Country Analysis – US, Canada, UK, Germany, China, Japan, India,
Brazil (Actual Period: 2014-2018, Forecast Period: 2019-2024)

  • Central Nervous System Therapeutic Market – Size and Growth
  • By Disease (Cancer, Neurovascular, Degenerative disorder, Mental
    Health, Trauma, Infection)

Other Report Highlights

  • Market Dynamics – Drivers and Restraints
  • Market Trends
  • Porter Five Force Analysis
  • Policy and Regulatory Landscape
  • Competitive Landscape
  • Company Analysis – Biogen, Pfizer, Teva Pharmaceuticals, Novartis,
    Johnson & Johnson, Shire, Merck & Co, AstraZeneca, Otsuka
    Pharmaceutical, Eli Lilly

Key Topics Covered

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Central Nervous System Therapeutic Market: Product Outlook

5. Global Central Nervous System Therapeutic Market: Growth and
Forecast

5.1 By Value (2014-2018)

5.2 By Value (2019-2024)

6. Global Central Nervous System Therapeutic Market: Segment
Analysis

6.1 Global Central Nervous System Therapeutic Market Size, By Type:
Breakdown (%)

6.1.1 Global Central Nervous System Therapeutic Market Size, By Type,
2018 (%)

6.1.2 Global Central Nervous System Therapeutic Market Size, By Type,
2024 (%)

6.2 Global Cancer Market, By Value (2014-2024)

6.3 Global Neurovascular Market, By Value (2014-2024)

6.4 Global Neurodegenerative disorder Market, By Value (2014-2024)

6.5 Global Mental Health Market, By Value (2014-2024)

6.6 Global Trauma Market, By Value(2014-2024)

6.7 Global Infection Market, By Value (2014-2024)

7. Global Central Nervous System Therapeutic Market: Regional
Analysis

7.1 Global Central Nervous System Therapeutic Market Size, By Region:
Breakdown (%)

7.2 North America Central Nervous System Therapeutic Market: Growth and
Forecast

7.3 North America Central Nervous System Therapeutic Market: Country
Analysis (U.S and Canada)

7.4 Europe Central Nervous System Therapeutic Market: Growth and Forecast

7.5 Europe Central Nervous System Therapeutic Market: Country Analysis
(U.K and Germany)

7.6 APAC Central Nervous System Therapeutic Market: Growth and Forecast

7.7 APAC Central Nervous System Therapeutic Market: Country Analysis
(Japan, India and China)

7.8 RoW Central Nervous System Therapeutic Market: Growth and Forecast

7.9 RoW Central Nervous System Therapeutic Market: Country Analysis
(Brazil)

8. Global Central Nervous System Therapeutic Market Dynamics

8.1 Global Central Nervous System Therapeutic Market Drivers

8.2 Global Central Nervous System Therapeutic Market Restraints

9. Global Central Nervous System Therapeutic Market Trends

10. Porter Five Force Analysis

11. SWOT Analysis

12. Supply Chain Analysis

13. Policy and Regulatory Landscape

14. Company Profiles

14.1 Biogen

14.2 Pfizer

14.3 Teva Pharmaceuticals

14.4 Novartis

14.5 Johnson & Johnson

14.6 Shire

14.7 Merck & Co.

14.8 AstraZeneca

14.9 Otsuka Pharmaceutical

14.10 Eli Lilly

For more information about this report visit https://www.researchandmarkets.com/r/4kblzv

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Central
Nervous System Drugs

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.